Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

artemether / lumefantrine Oral Tablet [Coartem]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Dried leaf Artemisia annua (DLA) has shown efficacy against Plasmodium sp. in rodent studies and in small clinical… Expand
  • figure 2
  • table 1
  • figure 1
Is this relevant?
2013
2013
BackgroundSafety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
The interest in hot-melt extrusion as a drug delivery technology for the production of solid dispersion is growing rapidly… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2009
Review
2009
Artemether and lumefantrine (AL), the active constituents of Coartem® exhibit complementary pharmacokinetic profiles. Artemether… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
Review
2009
Review
2009
Infants and children under five years of age are the most vulnerable to malaria with over 1,700 deaths per day from malaria in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2009
2009
BackgroundArtemether/Lumefantrine (Coartem®) has been used as a first-line treatment for uncomplicated Plasmodium falciparum… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2008
2008
BackgroundNumerous trials have demonstrated high efficacy and safety of artemisinin-based combination therapy (ACT) under… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2008
2008
BackgroundArtemether/lumefantrine (AL) has been adopted as the treatment of choice for uncomplicated malaria in Kenya and other… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BackgroundIn view of the high level of chloroquine resistance in many countries, WHO has recommended the use of combination… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
BackgroundSentinel site surveillance of antimalarials by in-vivo therapeutic efficacy studies in Zambia is one of the key… Expand
  • table 1
  • table 2
Is this relevant?